Skip to main content
. 2024 Jul 29;25(15):8285. doi: 10.3390/ijms25158285
  • CE: Cholesterol ester

  • Cer: Ceramides

  • CLD: Chronic liver disease

  • DG: Diglycerides

  • DiHETrEs: Dihydroxy-eicosatrienoic acids

  • DNL: De novo lipogenesis

  • FA: Fatty acid

  • FC: Free cholesterol

  • LCFA: Long-chain fatty acid

  • LC-MS: Liquid chromatography–mass spectrometry

  • LPC: Lysophosphatidylcholine

  • LFAT: high-fat liver

  • HCC: Hepatocellular carcinoma

  • HH: Hereditary hemochromatosis

  • HETEs: Hydroxyeicosatetraenoic acids

  • IHTG: Intrahepatic triglyceride

  • IR: Insulin Resistance

  • MALDI-MSI: Matrix-assisted laser desorption/ionization–mass spectrometry imaging

  • MetS: Metabolic syndrome

  • MUFA: Monounsaturated fatty acid

  • NAFLD: Non-alcoholic fatty liver disease

  • NEFA: Non-esterified fatty acid

  • NMR: Nuclear magnetic resonance

  • PC: Phosphatidylcholine

  • PE: Phosphatidylethanolamine

  • PhC: Phosphocholine

  • PL: Phospholipid

  • PE-pl: PE-based plasmalogens

  • PNPLA3: Patatin-like phospholipase domain containing 3

  • PUFA: Polyunsaturated fatty acid.

  • RBC: Red blood cell

  • SG: Sleeve gastrectomy

  • SFA: Saturated fatty acid

  • SM: Sphingomyelin

  • S1P: Sphingosine 1 phosphate

  • TG: Triglyceride

  • TM6SF2: Transmembrane 6 superfamily member 2

  • T2DM: Type 2 Diabetes mellitus

  • UPLC MS-QTOF: Ultraperformance liquid chromatography–Time-of-flight mass spectrometry